Gerresheimer (GRRMF) Stock Price, News & Analysis

Company Overview

Error: Response status code does not indicate success: 503 (Service Unavailable).

Key Stats

• Today's Range: $36.83 to $36.83
• 50-Day Range: $36.83 to $51.65
• 52-Week Range: $36.83 to $114.50
• Volume: N/A
• Average Volume: 795 shs
• Market Capitalization: N/A
• P/E Ratio: 16.22
• Dividend Yield: 1.41%
• Price Target: N/A
• Consensus Rating: Hold

Gerresheimer Stock Analysis - MarketRank™

Gerresheimer scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gerresheimer.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Gerresheimer is 16.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 231.42.

Price to Earnings Ratio vs. Sector

The P/E ratio of Gerresheimer is 16.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.03.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 7330, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 0.27%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Gerresheimer does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 7330, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 0.27%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: -0.04

News Sentiment

Gerresheimer has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Gerresheimer this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gerresheimer insiders have not sold or bought any company stock.

Percentage Held by Institutions

53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GRRMF Stock Analysis - Frequently Asked Questions

How have GRRMF shares performed this year?

Gerresheimer's stock was trading at $69.75 on January 1st, 2025. Since then, GRRMF shares have decreased by 47.2% and is now trading at $36.83.

How do I buy shares of Gerresheimer?

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRRMF
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: 49 211 6181 00
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 16.22
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A